Categories: Health

Transactions under Novonesis share buyback program

Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated  1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025.

Please read the full announcement in PDF.

Attachment

GlobeNews Wire

Recent Posts

ICFAI Business School Opens IBSAT 2026 Registrations, Announces 10 Crore Scholarship Program

HYDERABAD, India, July 1, 2026 /PRNewswire/ -- ICFAI Business School (IBS) opened the registration process for…

3 hours ago

FitsAir and Amadeus sign global distribution agreement to expand international reach

COLOMBO, Sri Lanka, July 1, 2026 /PRNewswire/ -- FitsAir, Sri Lanka's privately owned international airline,…

3 hours ago

MEXC SpaceX Products See Surging Demand as Cumulative Futures Trading Volume Surpasses $7.1 Billion

VICTORIA, Seychelles, June 30, 2026 /PRNewswire/ -- MEXC, a pioneer in 0-fee digital asset trading,…

3 hours ago

STARTRADER Launches Pre-IPO Trading Products for OpenAI and Anthropic

The new CFD instruments give traders early exposure to two of the world's most prominent…

3 hours ago

Apollo Hospitals, Bangalore Becomes First in India to Receive Dual American Heart Association Certification for Stroke and Chest Pain Care

BENGALURU, India, June 30, 2026 /PRNewswire/ -- Apollo Hospitals, Bangalore has become the first hospital in…

7 hours ago

Basecamp Research brings EDEN’s antibiotic and vaccine design models to Claude Science

Scientists can now design potent antibiotics and rapidly prioritise vaccine targets through Claude Science, thanks…

9 hours ago